References
- 1. ALAMANOS Y, VOULGARI PV, DROSOS AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006; 36(3): 182-8.
- 2. VOLLERTSEN RS, CONN DL. Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am 1990; 16(2): 445-61.
- 3. KHASNIS A, LANGFORD CA. Update on vasculitis. J Allergy Clin Immunol. 2009; 123: 1226-36.
- 4. YOUNG A, KODURI G. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007; 21(5): 907-27.
- 5. GENTA MS, GENTA RM, GABAY C. Systemic rheumatoid vasculitis: a review. Semin Arthritis Rheum. 2006; 36: 88–98.
- 6. TURESSON C, MATTESON EL. Vasculitis in rheumatoid arthritis. Curr Opin Rheumatol. 2009; 21(1): 35-40.
- 7. WATTS RA, MOONEY J, LANE SE, SCOTT DG. Rheumatoid vasculitis: becoming extinct? Rheumatology. 2004; 43: 920–3.
- 8. BARTELS CM, BRIDGES AJ. Rheumatoid vasculitis: vanishing menace or target for new treatments? Curr Rheumatol Rep 2010; 12(6): 414-9.
- 9. MAKOL A, MATTESON EL, WARRINGTON KJ. Rheumatoid vasculitis: an update. Curr Opin Rheumatol 2015; 27(1): 63-70.
- 10. MAKOL A, CROWSON CS, WETTER DA, SOKUMBI O, MATTESON EL, WARRINGTON KJ. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford). 2014; 53(5): 890-9.
- 11. NTATSAKI E, MOONEY J, SCOTT DG, WATTS RA. Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology (Oxford) 2014; 53(1): 145-52.
- 12. KANEKO S, YAMASHITA H, SUGIMORI Y, TAKAHASHI Y, KANEKO H, KANO T, MIMORI A. Rheumatoid arthritis-associated aortitis: a case report and literature review. Springerplus 2014; 3: 509.
- 13. JAMES W, BERGER T, ELSTON D. Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. 2005.
- 14. RAPINI RP, BOLOGNIA JL, JORIZZO JL. Dermatology: 2-Volume Set. St. Louis: Mosby. 2007.
- 15. MAGRO CM, CROWSON AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 2003; 30(1): 1-10.
- 16. CHEN KR, TOYOHARA A, SUZUKI A, MIYAKAWA S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol 2002; 147(5): 905-13
- 17. PUÉCHAL X, SAID G, HILLIQUIN P, COSTE J, JOB-DESLANDRE C, LACROIX C, MENKÈS CJ. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38(11): 1618-29.
- 18. ZOLCINSKI M, BAZAN-SOCHA S, ZWOLINSKA G, MUSIAL J. Central nervous system involvement as a major manifestation of rheumatoid arthritis. Rheumatol Int. 2008; 28: 281–3.
- 19. AKROUT R, BENDJEMAA S, FOURATI H, EZZEDDINE M, HACHICHA I, MHIRI C, BAKLOUTI S. Cerebral rheumatoid vasculitis: a case report. J Med Case Rep 2012; 6: 302.
- 20. MRABET D, MEDDEB N, AJLANI H, SAHLI H, SELLAMI S. Cerebral vasculitis in a patient with rheumatoid arthritis. Joint Bone Spine 2007; 74(2): 201-4.
- 21. CABALLOL PONS N, MONTALÀ N, VALVERDE J, BRELL M, FERRER I, MARTINEZ-YÉLAMOS S. Isolated cerebral vasculitis associated with rheumatoid arthritis. Joint Bone Spine 2010; 77(4): 361-3.
- 22. LASKARI K, AHMADI-SIMAB K, LAMKEN M, et al. Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis? Ann Rheum Dis. 2010; 69: 469–71.
- 23. SPOERL D, PERS YM, JORGENSEN C. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: two case reports and review of literature. Allergy Asthma Clin Immunol 2012; 8(1): 19.
- 24. RUIZ-ZORRILLA A, PICAZO M, GONZÁLEZ-ÁLVARO I, GÓMEZ-GIL R, GARCIA DE VICUNA R. Vasculitis associated with anti-neutrophil cytoplasmic autoantibodies in rheumatoid arthritis. Report of a case of microscopic polyangiitis and another case of Wegener’s granulomatosis. Reumatol Clin 2005; 1(1): 52-5.